2020 Glaucoma Surgical Device Market Report: A Global Analysis for 2019 to 2025, August, 2020

The 2020 Glaucoma Surgical Device Market Report offers a comprehensive analysis of the 2020 global market for glaucoma devices, as well as a discussion of important trends and key factors shaping future success. The report covers prevalence and forecasts for glaucoma worldwide and discusses the ophthalmologists who treat glaucoma. It also examines the role of surgical intervention, the market dynamics for currently commercialized products, and the pipeline of investigational devices that may offer improved outcomes. Product demand is forecast in units and dollars, and market shares are analyzed by product category.

The report covers five product categories: minimally invasive glaucoma surgery (MIGS), trab plus devices, tube shunts, canal surgery devices, and glaucoma lasers. Each segment includes an analysis of market competitors and five-year market forecasts for units and dollars. 

Also included in the report:

• Background information about glaucoma, glaucoma populations, and glaucoma diagnosis.
• Estimates of current sales and sales forecasts for glaucoma devices, including average prices and total revenue.
• Profiles of prospective device buyers, including ophthalmologists, ophthalmic specialists, optometrists, and general medical doctors. Information about manufacturers.
• Current reimbursement rates. Five basic surgery categories divided into 15 different product types, which are profiled.
• Analysis on the percentage of the different types of glaucoma surgeries being performed by US cataract surgeons, glaucoma specialists, and general ophthalmologists.
• New section on key opinion leaders’ decision making on glaucoma surgery options.
• Analysis of COVID-19 impact on 2020 sales and expected recovery in 2021 and through 2025.
• Tracking of the progress being made in sustained drug delivery devices in a separate section of the report.
• New listing of 14 early-stage glaucoma surgery development projects.
• Details a number of mergers and acquisitions recently announced and their expected market impact.

2 licensing types are available for this report:

• The price of the report is $7,000 for a single-user license.
• The price of the enterprise license is $10,500 (includes supplemental Excel file with all the tables and figures in the report).

Both licenses include an electronic PDF. Printed copies may be purchased for an additional $250.

SINGLE USER LICENSE

• The Single User License allows for the use of a report by a single user within one corporate location.
• The report paper copy may not be reproduced (additional paper copies available for purchase).
• Report PDF copy can not be copied (if purchased) and must remain on one computer (not a company server).
• Only a single copy of the publication may be printed for internal use.
• Users may include information in the report in presentations and internal reports by providing full copyright credit to Market Scope.
• Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

ENTERPRISE LICENSE

• The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.
• Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.
• Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Market Scope.
• Purchase price includes both a paper copy and printable PDF file of the report. (purchasing organization may print multiple copies for use within the organization)
• Purchase price includes a supplemental Excel file containing all the tables and figures included in the purchased report.